Histone deacetylase ( HDAC ) inhibitors as single agents induce multiple myeloma cell death principally through the inhibition of class I HDAC
Sridurga Mithraprabhu, Tiffany Khong, Simon S. Jones, Andrew Spencer
Abstract
Sridurga Mithraprabhu, Tiffany Khong, Simon S. Jones, Andrew Spencer
Abstract
The British Journal of Haematology publishes original research papers in clinical, laboratory and experimental haematology. The Journal also features annotations, reviews, short reports, images in haematology and Letters to the Editor.
OpenAlex reports 39 citations for this work. Citation counts describe recorded attention and do not establish research quality.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
The British Journal of Haematology publishes original research papers in clinical, laboratory and experimental haematology. The Journal also features annotations, reviews, short reports, images in haematology and Letters to the Editor.
Key concepts: Histone deacetylase, HDAC11, Multiple myeloma, Histone deacetylase 5, HDAC10, HDAC4, Cancer research, Histone